Optometry Times® news summary 8/2/2020

Aug 2, 2020

Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director

Editor in Chief and Content Channel Director Gretchyn M. Bailey, NCLC, FAAO, shares news updates for August 2, 2020.

Related: Optometry Times® news summary 7/15/2020

Related Videos

Dr. Mohammad Rafieetary

Related Content

AOA 2023: Championing the future of optometry

Practical management EP 14: Your practice-purchase checklist

April 27th 2023

Vyluma announces FDA acceptance of NDA for NVK002 for treatment of pediatric myopia

Community care: Connecting mentorship and representation

April 26th 2023

Glaukos’ phase 3 confirmatory trial for Epioxa reaches pipeline enrollment milestone

Bausch + Lomb celebrates US launch of Infuse Multifocal SiHy daily disposable contact lenses

AOA 2023: Championing the future of optometry

Practical management EP 14: Your practice-purchase checklist

April 27th 2023

Vyluma announces FDA acceptance of NDA for NVK002 for treatment of pediatric myopia

Community care: Connecting mentorship and representation

April 26th 2023

Glaukos’ phase 3 confirmatory trial for Epioxa reaches pipeline enrollment milestone

Bausch + Lomb celebrates US launch of Infuse Multifocal SiHy daily disposable contact lenses

AOA 2023: Championing the future of optometry

Practical management EP 14: Your practice-purchase checklist

April 27th 2023

Vyluma announces FDA acceptance of NDA for NVK002 for treatment of pediatric myopia

Community care: Connecting mentorship and representation

April 26th 2023

Glaukos’ phase 3 confirmatory trial for Epioxa reaches pipeline enrollment milestone

Bausch + Lomb celebrates US launch of Infuse Multifocal SiHy daily disposable contact lenses

Related Content

Image Credit: © andreykr - stock.adobe.com

AOA 2023: Championing the future of optometry

Practical management EP 14: Your practice-purchase checklist

Practical management EP 14: Your practice-purchase checklist

April 27th 2023

Image Credit: © Kiryakova Anna - stock.adobe.com

Vyluma announces FDA acceptance of NDA for NVK002 for treatment of pediatric myopia

Jill Saxon, OD, executive director of professional strategy at Bausch + Lomb

Community care: Connecting mentorship and representation

April 26th 2023

Image Credit: © Zarina Lukash - stock.adobe.com

Glaukos’ phase 3 confirmatory trial for Epioxa reaches pipeline enrollment milestone

presbyope inserting Bausch + Lomb Infuse Multifocal SiHy daily disposable contact lens following US launch - Image credit: Adobe Stock/©Kitreel

Bausch + Lomb celebrates US launch of Infuse Multifocal SiHy daily disposable contact lenses

Terms & Conditions

Do not sell my Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.